Related Experiment Videos
Structural and functional consequences of minoxidil-induced cardiac hypertrophy
C S Moravec1, T Ruhe, J R Cifani
1Department of Cardiovascular Biology, Cleveland Clinic Foundation, Ohio.
Summary
Minoxidil, an antihypertensive drug, causes cardiac enlargement in normotensive rats. This cardiac hypertrophy is not solely due to pressure overload, impacting heart muscle function.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Cardiac Remodeling
Background:
- Minoxidil is an effective antihypertensive agent, particularly for resistant cases.
- Despite lowering blood pressure, minoxidil does not regress existing cardiac hypertrophy.
- Minoxidil administration to normotensive animals induces cardiac enlargement.
Purpose of the Study:
- To investigate the mechanism of minoxidil-induced cardiac hypertrophy.
- To determine the consequences of this hypertrophy on myocardial structure and function.
- To understand the dissociation between blood pressure control and cardiac enlargement.
Main Methods:
- Administration of minoxidil to normotensive rats.
- Analysis of cardiac muscle structure (ventricles, septum) and myocyte size.
- Functional assessment of left ventricular papillary muscles.
Main Results:
- Minoxidil induced significant enlargement of the left ventricle, right ventricle, and interventricular septum.
- Right ventricular enlargement was linked to increased myocyte cross-sectional area, suggesting pressure overload.
- Left ventricular and septal enlargement involved mechanisms beyond pressure overload.
- Hypertrophied papillary muscles showed slower contraction and relaxation despite normal force development.
Conclusions:
- Minoxidil causes cardiac enlargement through multiple mechanisms, not solely pressure overload.
- The observed cardiac hypertrophy affects myocardial function, with slower muscle dynamics.
- Findings highlight potential risks of minoxidil use and the importance of understanding its cardiac effects.